CKD. Control BP. Cardioprotection. 🧬❤️📉

BP Lowering in CKD: Consistent. Comprehensive. Compelling. 📉🫀 A landmark individual-participant meta-analysis (285K+ patients) shows that every 5 mm Hg reduction in systolic BP reduces major cardiovascular events by ~10%—across all CKD stages. Key insight: the benefit holds even at lower BP levels and across drug classes. ⚖️ But in CKD + diabetes, the effect attenuates—reminding us that biology resists simplicity. 🧠 The message is clear: BP control remains one of the most powerful, scalable tools in CKD care. Precision is next. Implementation is everything. 🚀